Trupanion, Inc. (NASDAQ:TRUP) Stock Has Average Target Price of $40.00 According to Analysts

Trupanion logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have an average Hold rating on Trupanion, with five of six analysts recommending hold and one recommending buy. Their average 12-month price target is $40.
  • Recent analyst actions were mixed: Piper Sandler lowered its target to $32 and Zacks downgraded the stock to hold, while Cantor Fitzgerald raised its target to $33.
  • Trupanion beat quarterly earnings and revenue estimates, reporting EPS of $0.21 versus $0.17 expected and revenue of $405.59 million versus $402.53 million. Insiders sold 71,605 shares worth about $2.43 million over the past three months.
  • Interested in Trupanion? Here are five stocks we like better.

Shares of Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) have been given an average rating of "Hold" by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $40.00.

TRUP has been the subject of a number of research reports. Piper Sandler cut Trupanion from an "overweight" rating to a "neutral" rating and reduced their price objective for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Zacks Research cut shares of Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 24th. Cantor Fitzgerald upped their price objective on shares of Trupanion from $30.00 to $33.00 and gave the stock a "neutral" rating in a research report on Monday, November 9th. Weiss Ratings upgraded shares of Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, September 29th. Finally, Wall Street Zen raised shares of Trupanion from a "hold" rating to a "buy" rating in a report on Saturday, November 7th.

View Our Latest Stock Analysis on Trupanion

Insider Buying and Selling

In other news, CEO Margaret Tooth sold 2,000 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $36.46, for a total transaction of $72,920.00. Following the completion of the transaction, the chief executive officer directly owned 182,952 shares of the company's stock, valued at approximately $6,670,429.92. This represents a 1.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Howard E. Rubin sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $35.57, for a total value of $355,700.00. Following the completion of the sale, the director directly owned 183,288 shares of the company's stock, valued at $6,519,554.16. This represents a 5.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 71,605 shares of company stock worth $2,433,483 in the last three months. Company insiders own 5.58% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Bank of New York Mellon Corp acquired a new position in Trupanion during the second quarter worth $4,631,000. Bank of America Corp DE acquired a new stake in Trupanion in the second quarter valued at $14,262,000. Renaissancere Holdings Ltd. acquired a new stake in Trupanion in the second quarter valued at $6,514,510. Legal & General Group Plc acquired a new stake in Trupanion in the second quarter valued at $1,938,000. Finally, GSA Capital Partners LLP purchased a new position in shares of Trupanion in the second quarter valued at $1,394,000.

Trupanion Stock Performance

Shares of TRUP opened at $36.55 on Wednesday. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of 59.92, a price-to-earnings-growth ratio of 1.67 and a beta of 1.27. Trupanion has a 52-week low of $21.16 and a 52-week high of $38.87. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.24. The stock has a 50 day moving average price of $28.10 and a 200 day moving average price of $26.79.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, November 5th. The financial services provider reported $0.21 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.04. Trupanion had a net margin of 1.71% and a return on equity of 6.71%. The firm had revenue of $405.59 million for the quarter, compared to the consensus estimate of $402.53 million. During the same period last year, the firm posted $0.13 EPS. Research analysts predict that Trupanion will post 0.68 EPS for the current fiscal year.

About Trupanion

(Get Free Report)

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.

Further Reading

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines